Anadolu Medical Center
| Turkey | Thailand | South Korea | |
| Proton-beam therapy | from AUD $97,198 | from AUD $124,968 | from AUD $30,548 |
| High intensity focused ultrasound ablation (HIFU) | from AUD $5,554 | from AUD $11,803 | from AUD $17,357 |
| CyberKnife | from AUD $6,596 | from AUD $41,656 | from AUD $15,968 |
| Chemotherapy for breast cancer | from AUD $1,666 | from AUD $4,166 | from AUD $26,660 |
| Radiation therapy for colorectal cancer | from AUD $9,720 | from AUD $7,637 | - |
Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.
Dr. Esra Ozbasli is a board-certified OB-GYN and Genital Cosmetic Surgeon in Istanbul. She specializes in robotic surgery and women's aesthetic procedures. Dr. Ozbasli practiced as an academician at Acıbadem University for 12 years. She is also ECFMG-accredited for medical practice in the United States.
Dr. Cem Yalcinkaya is an associate professor and gynecologic oncologist at Anadolu Medical Center. He specializes in fertility-sparing surgeries and robotic procedures for gynecologic cancers. Dr. Yalcinkaya holds a robotic surgeon certificate for the DaVinci system. He successfully passed the European Society of Gynecologic Oncology (ESGO) exam in 2019.
Dr. Banu Atalar is a professor and radiation oncologist at Anadolu Medical Center. She is an Honorary Fellow of the American College of Radiology (H.FACR). She completed a clinical research fellowship in stereotactic radiosurgery at Stanford University. Stereotactic radiosurgery and MR-guided adaptive SRS make up 75% of her clinical practice.
Leiomyosarcoma treatment in Turkey involves surgical resection, radiation, and systemic therapies. Specialist centres like Anadolu Medical Center and Memorial Bahçelievler use JCI-accredited protocols. Options include robotic surgery, TrueBeam radiotherapy, and targeted immunotherapy. These manage both localised and metastatic disease effectively.
Bookimed Expert Insight: Turkish oncology hubs have multi-disciplinary tumour boards. This gives them a significant advantage for complex leiomyosarcoma. Anadolu Medical Center is affiliated with Johns Hopkins. This lets specialists like Prof. Dr Bulent Karagoz coordinate surgery and systemic therapy. This integrated approach is critical. Data shows surgery remains the most decisive treatment for this rare cancer.
Patient Consensus: Patients in Turkey highlight that surgery is the most effective way to manage leiomyosarcoma tumours. Many note that a second opinion from Turkish specialists often changes the initial plan. This change is for the better.
Turkish hospitals like Anadolu Medical Center and Memorial Şişli Hospital specialise in sarcoma care. They focus on leiomyosarcoma as well. These centres use multidisciplinary tumour boards to manage rare smooth muscle cancers. Treatment options include precision radiotherapy like CyberKnife and surgical resection performed by internationally trained specialists.
Bookimed Expert Insight: Anadolu Medical Center stands out for two reasons. It is affiliated with Johns Hopkins Medicine and treats 65,000 patients annually. This partnership provides access to international treatment protocols. Specialists like Prof. Dr Yesim Yildirim have trained in the UK and Israel. They bring diverse expertise to complex sarcoma cases.
Patient Consensus: Patients recommend requesting a dedicated soft-tissue sarcoma team rather than general oncology specialists. They note that medical staff in Istanbul treat cases with high respect and professionalism.
Turkish oncology clinics use multidisciplinary tumour boards to manage rare cancers like leiomyosarcoma. Specialists at JCI-accredited facilities collectively review diagnostic scans, pathology, and genetic profiles. This coordinated approach provides precise surgical planning. It also provides sequential care for complex soft-tissue and uterine sarcomas.
Bookimed Expert Insight: While many centres treat cancer, Memorial Göztepe Hospital is different. It specifically organises its care around multidisciplinary boards. These boards include a clinical research unit. This setup provides access to global treatment innovations. Patients benefit from a system that allows over 40 individuals to receive chemotherapy simultaneously. All treatments occur under team-based supervision.
Patient Consensus: Patients note the importance of verifying the specific sarcoma team. This is vital for rare cases in Turkey. They also emphasise the importance of having pathology re-reviewed by the hospital's own specialists. This helps make sure the leiomyosarcoma is correctly classified before surgery.